direct to consumer

The deal has brought the consumer telehealth and wellness company approximately $280 million in proceeds that it will use to grow and invest in new product categories.

Customers will now be able to use the services to get eczema treatment, as well as prescription antiperspirant and dandruff shampoo.

New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.

According to StartUp Health’s year-end report, digital health funding is down from 2014.